Capricor Therapeutics
CAPR
#6423
Rank
NZ$0.99 B
Marketcap
$21.45
Share price
-1.53%
Change (1 day)
139.03%
Change (1 year)

P/S ratio for Capricor Therapeutics (CAPR)

P/S ratio as of April 2025 (TTM): 26.8

According to Capricor Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.11. At the end of 2024 the company had a P/S ratio of 28.7.

P/S ratio history for Capricor Therapeutics from 2002 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202428.7380.68%
20235.98-84.34%
202238.2-86.78%
202128927.81%
20202263295.51%
20196.66-13.53%
20187.70-58.48%
201718.53.93%
201617.834.86%
201513.225.58%
201410.5
2013N/A-100%
201210.7-32.86%
201116.0
2010N/A
2009N/A
2007> 1000
2003> 100091.37%
2002920

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
266 891.59%๐Ÿ‡บ๐Ÿ‡ธ USA
15.8-41.09%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19-84.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.47-83.33%๐Ÿ‡บ๐Ÿ‡ธ USA
202 653.54%๐Ÿ‡บ๐Ÿ‡ธ USA
22.6-15.75%๐Ÿ‡บ๐Ÿ‡ธ USA